drugset
drugset / Trial / NCT00000246

Rapid Benzodiazepine Detoxification Using Flumazenil - 1

NCT00000246 ↗

Phase 2 Completed 10 enrolled Yale University National Institute on Drug Abuse (NIDA) · collab
Treatment

Summary

The purpose of this study is to verify the hypothesis that the benzodiazepine antagonist, flumazenil, will reduce acute benzodiazepine withdrawal.

Timeline

Start
1993-01
Primary completion
1994-12
Completion
1994-12

Publications

  • Background Woods, et al., Soc Neuroscience Abstracts 21: 2098, 1995.

Drugs

EvaluationDrugModalityDoseRoute
Subject Flumazenil Small molecule — —

Indications

substance-related disorder